Company Updates

Big Expectations From Reliance Energy - Gujral

Technical Analyst Ashwani GujralTechnical Analyst, Ashwani Gujral is of the view that Reliance Energy can touch Rs 720.

Mr. Gujral said that Tata Power and Reliance Energy are the strongest options. Reliance Energy beyond Rs 580 is poised to go up to Rs 720 and for Tata Power, Rs 620 is a key level that should probably be headed in the direction of Rs 750-760.

“I think some rub off from the capital goods space, those electrical equipment stocks is now rubbing off even to the energy stocks,” He added.

Bajaj Auto Loses on Lack of Activity

Bajaj AutoAfter turning ex-dividend, Bajaj Auto lost 1.61% to Rs 2,095 in afternoon trading.

Jai Parabolic Springs Advances On Merger Approval

Jai Parabolic Jai Parabolic Springs Ltd.Springs Ltd. climbed up by its maximum daily limit of 5 percent to 29.50 rupees as the board okayed its merger deal with Jamna Auto Industries. The company made the declaration in trading hours. The scrip had touched its intraday low of Rs 28 during the day.
Today, about 16,712 shares were traded in the scrip. In the past one quarter, the stock had an average daily volume of 11,212 shares. At its existing price of Rs 29.50, the scrip trades at a PE multiple of 10.13, based on year ended March 2007 EPS of Rs 2.91.

BHEL Is The Best Order-N-Investment Combination

Lengthening itsBharat Heavy Electricals current rally on continued buying, Bharat Heavy E

Block Deal Lifts EIH

In early hours, EIH gained 3.10% to Rs 104.60 as a big block deal executed at Rs 102 per share on Bombay Stock Exchange.

The company’s share price touched a highest peak of Rs 105 and a low of Rs 100.95 during the day. On 13 September 2006, the scrip has had its 52-week high of Rs 127.

The block deal was of 19 lakh shares and was struck today. The overall volume was 19.58 lakh shares and the average daily volume in the stock was 50,051 shares in the past one quarter.

Ranbaxy Laboratories Excited On USFDA Approval For Stress-Reliever

Ranbaxy LaboratoriesRanbaxy Laboratories gained ground after declaring it got an approval to make and sell Amlodipine Besylate in the United States. Its share price bobbed up 1.82% to Rs 358.25.
The shared price had reached a high of Rs 358.40 and a low of Rs 353.95 during the day. In the last one quarter, the company’s scrip had an average daily volume of 2.71 lakh shares on BSE.
At present level of Rs 358.25, the stock trades at a PE multiple of 26.14 based on its Q1 March 2007 annualized earning per share (EPS) of Rs 13.7.

Pages